Diagnostic and Risk Stratification Value of Serum 8-Hydroxy-2-Deoxyguanosine in Women with Suspected Breast Carcinoma in Bangladesh: A Cross-Sectional Analytical Study.
S Ferdoushi, K F Khanam, F Haque, S Debnath, R E Mortaz, F Afroz, S M Ashrafozzaman
{"title":"Diagnostic and Risk Stratification Value of Serum 8-Hydroxy-2-Deoxyguanosine in Women with Suspected Breast Carcinoma in Bangladesh: A Cross-Sectional Analytical Study.","authors":"S Ferdoushi, K F Khanam, F Haque, S Debnath, R E Mortaz, F Afroz, S M Ashrafozzaman","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Breast carcinoma is a leading cause of carcinoma-related morbidity and mortality among women worldwide, with a rising burden in low- and middle-income countries. Early differentiation between malignant and benign breast lesions remains a major challenge in resource-constrained settings, where access to imaging and histopathology is often limited. Oxidative DNA damage plays a key role in carcinogenesis and serum 8-hydroxy-2-deoxyguanosine (8-OHdG) has emerged as a potential non-invasive biomarker; however, evidence from Bangladesh is scarce. The objective of this study was to evaluate the diagnostic value of serum 8-hydroxy-2-deoxyguanosine and its association with clinicodemographic and histopathological characteristics among women with suspected breast carcinoma. This cross-sectional analytical study was conducted among 81 women presenting with clinically suspected breast lumps at Bangladesh Medical University, Dhaka, Bangladesh from July 2023 to June 2024. Participants underwent histopathological examination and were classified into breast carcinoma (n=42) and benign breast disease (n=39) groups. Serum 8-OHdG levels were measured using an enzyme-linked immunosorbent assay. Diagnostic performance was assessed using receiver operating characteristic analysis. Associations between 8-OHdG and clinical variables were examined using correlation analysis and multivariable logistic regression. The mean age of participants was higher in the breast carcinoma group compared with the benign group (44.33±9.03 vs 35.59±10.43 years; p=0.0003). Serum 8-OHdG levels were significantly elevated in breast carcinoma (7.40±1.57 ng/mL) compared with benign disease (5.16±1.53 ng/mL; p<0.001. At a cut-off value of 6.0 ng/mL, serum 8-OHdG showed a sensitivity of 71.4% and specificity of 69.2%, with an overall diagnostic accuracy of 70.4%. Increasing age, postmenopausal status and family history were significantly associated with malignancy. Serum 8-OHdG is significantly elevated in breast carcinoma and demonstrates good sensitivity for differentiating malignant from benign breast lesions. It may serve as a practical, non-invasive biomarker for diagnostic triage, particularly in resource-limited settings.</p>","PeriodicalId":94148,"journal":{"name":"Mymensingh medical journal : MMJ","volume":"35 4","pages":"1263-1269"},"PeriodicalIF":0.0000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mymensingh medical journal : MMJ","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Breast carcinoma is a leading cause of carcinoma-related morbidity and mortality among women worldwide, with a rising burden in low- and middle-income countries. Early differentiation between malignant and benign breast lesions remains a major challenge in resource-constrained settings, where access to imaging and histopathology is often limited. Oxidative DNA damage plays a key role in carcinogenesis and serum 8-hydroxy-2-deoxyguanosine (8-OHdG) has emerged as a potential non-invasive biomarker; however, evidence from Bangladesh is scarce. The objective of this study was to evaluate the diagnostic value of serum 8-hydroxy-2-deoxyguanosine and its association with clinicodemographic and histopathological characteristics among women with suspected breast carcinoma. This cross-sectional analytical study was conducted among 81 women presenting with clinically suspected breast lumps at Bangladesh Medical University, Dhaka, Bangladesh from July 2023 to June 2024. Participants underwent histopathological examination and were classified into breast carcinoma (n=42) and benign breast disease (n=39) groups. Serum 8-OHdG levels were measured using an enzyme-linked immunosorbent assay. Diagnostic performance was assessed using receiver operating characteristic analysis. Associations between 8-OHdG and clinical variables were examined using correlation analysis and multivariable logistic regression. The mean age of participants was higher in the breast carcinoma group compared with the benign group (44.33±9.03 vs 35.59±10.43 years; p=0.0003). Serum 8-OHdG levels were significantly elevated in breast carcinoma (7.40±1.57 ng/mL) compared with benign disease (5.16±1.53 ng/mL; p<0.001. At a cut-off value of 6.0 ng/mL, serum 8-OHdG showed a sensitivity of 71.4% and specificity of 69.2%, with an overall diagnostic accuracy of 70.4%. Increasing age, postmenopausal status and family history were significantly associated with malignancy. Serum 8-OHdG is significantly elevated in breast carcinoma and demonstrates good sensitivity for differentiating malignant from benign breast lesions. It may serve as a practical, non-invasive biomarker for diagnostic triage, particularly in resource-limited settings.
乳腺癌是全世界妇女癌症相关发病率和死亡率的主要原因,低收入和中等收入国家的负担日益加重。在资源有限的环境中,早期鉴别乳腺恶性和良性病变仍然是一个主要挑战,因为在这些环境中,获得影像学和组织病理学检查的机会往往有限。氧化性DNA损伤在癌症发生中起关键作用,血清8-羟基-2-脱氧鸟苷(8-OHdG)已成为一种潜在的非侵入性生物标志物;然而,来自孟加拉国的证据很少。本研究的目的是评估血清8-羟基-2-脱氧鸟苷的诊断价值及其与疑似乳腺癌妇女的临床人口学和组织病理学特征的关系。这项横断面分析研究于2023年7月至2024年6月在孟加拉国达卡的孟加拉国医科大学对81名临床疑似乳房肿块的妇女进行了研究。参与者接受组织病理学检查,并被分为乳腺癌组(n=42)和乳腺良性疾病组(n=39)。采用酶联免疫吸附法测定血清8-OHdG水平。使用受者工作特征分析评估诊断性能。采用相关分析和多变量logistic回归检验8-OHdG与临床变量的关系。乳腺癌组参与者的平均年龄高于良性组(44.33±9.03 vs 35.59±10.43岁;p=0.0003)。乳腺癌患者血清8-OHdG水平(7.40±1.57 ng/mL)明显高于良性疾病患者(5.16±1.53 ng/mL)